Neuropsychiatry

Showing 1 posts of 1 posts found.

Draig Therapeutics appoints Ivana Magovčević-Liebisch as President and CEO

November 5, 2025
Draig Therapeutics, Neuropsychiatry, neuroscience

Draig Therapeutics, a Welsh clinical-stage company developing glutamate and GABA-based treatments for neuropsychiatry, has appointed Ivana Magovčević-Liebisch as President and …

The Gateway to Local Adoption Series

Latest content